We attempted to predict epidemics of influenza B, focusing on B/Victoria/2/87-like (V) and B/Yamagata/16/88-like (Y) lineages, in Yamagata, Japan. 
INTRODUCTION
Influenza viruses are the most important cause of acute respiratory infections. In temperate regions, influenza occurs in winter epidemics that affect 1-5 % of the entire population and the total estimated cost of welfare may reach approximately US$ 10-60 million per million population in developed countries [1] . The strategy of the World Health Organization (WHO) against influenza is primarily to utilize vaccines in large-scale immunization programmes. Therefore, an analysis of antigenicity among circulating viruses is crucial and WHO has established a Global Influenza Surveillance Network to enable better vaccines to be produced. On the other hand, protective herd immunity against influenza viruses is an important factor in limiting the size of epidemics [1] . Thus both the antigenic analysis of circulating viruses and monitoring of herd immunity against them are important in realizing an effective anti-influenza programme.
The regular surveillance of influenza viruses in Japan has revealed that two or three subtypes of influenza A (H3), A (H1) and B have been co-circulating in recent years. Since 1996, H3 viruses have been circulating in every season and H1 viruses were associated with epidemics between the 1999-2000 and 2001-2002 seasons in Japan. Major epidemics of influenza B have occurred almost every 2 years ; in 1996-1997, 1998-1999, 2000-2001, 2001-2002 and 2002-2003 seasons [2, 3] . A similar epidemic pattern of influenza B was seen in Yamagata, which is located in the north-eastern part of Japan.
It is known that influenza B viruses can be divided into two antigenically distinct lineages, represented by B/Victoria/2/87 (V-lineage) and B/Yamagata/16/88 (Y-lineage), based on haemagglutination-inhibition (HI) tests using animal antisera and on genomic differences [4] [5] [6] [7] [8] [9] . The former lineage has been circulating in Japan since at least 1976 and the latter was recognized for the first time in a school outbreak in the spring of 1987 [4] . Although we have tried to predict the characteristics of influenza epidemics based on virus isolation and seroepidemiological analysis at a public-health laboratory, we have not yet succeeded in producing a perfect prediction. However, we have accumulated useful data on influenza B epidemiology, especially on the two influenza B lineages. The epidemiology of these two lineages still remains poorly understood. Herein, we describe our results of virus isolation since the 1996-1997 season and seroepidemiological data using sera collected in 2001 in Yamagata.
METHODS

Collection of specimens
Between January 1996 and June 2003, 9624 nasopharyngeal swab specimens were obtained from patients with acute respiratory infection (ARI) at paediatric clinics collaborating with the local health authority of Yamagata Prefecture for the surveillance of viral diseases in Japan. Patients were clinically diagnosed as having ARI with fever and/or cough and/or rhinorrhoea. The specimens were collected and placed immediately in tubes containing a transport medium, and transported to the Department of Microbiology, Yamagata Prefectural Institute of Public Health for virus isolation.
Human sera were collected between August and September 2001 for the national epidemiological surveillance of vaccine-preventable diseases led by the Ministry of Health, Labour and Welfare of Japan [12] . From residents who agreed to enrol in the programme in Yamagata we collected 31 sera from the 0-4 years age group, 25 from 5-9 years, 21 from 10-14 years, 39 from 15-19 years, 33 from 20-29 years, 24 from 30-39 years, 22 from 40-49 years, 21 from 50-59 years, and 21 from the o60 years age group.
Virus isolation and identification
Virus isolation was carried out using a microplate method. Briefly, human embryonic fibroblast (HEF), HEp-2 cell line of human larynx carcinoma, Vero line from African green monkey kidney, Madin-Darby Canine Kidney (MDCK), RD-18S line of a human rhabdomyosarcoma and GMK line from green monkey kidney origin, were prepared on the wells of a 96-well microplate [13, 14] . After centrifugation at 3000 rpm for 15 min, 75 ml of the supernatant was inoculated on to two wells of each cell line. The inoculated plates were incubated at 33 xC in an incubator. When a typical influenza virus cytopathic effect was observed, viral identification was carried out by means of a HI test. We For identification, 1% guinea-pig red blood cells and 0 . 5 % chicken red blood cells were used and the latter was also used for the seroepidemiological study.
Seroepidemiological study
Sera were treated with Receptor Destroying Enzyme (RDE ; Denka Seiken Co.) according to the manufacturers instructions. HI antibody titres were measured by a standard method [12] . Standard antigens of AK27-01 and JOHA5-99 viruses were provided either by NIIDJ or purchased from Denka Seiken Co. 
RESULTS
Influenza virus isolation in Yamagata
During the study period, we isolated 1124 influenza A (H3), 388 influenza A (H1) and 670 influenza B viruses. Among the influenza B viruses, 424 out of 670 strains were identified as V-lineage and 246 as Y-lineage (Fig. 1) 
Seroepidemiological study using standard and circulating viral antigens
To compare antigenicity among standard and circulating viral antigens in view of herd immunity, we measured HI antibody titres among people in Yamagata. The scatter plots of the HI antibody prevalence against YA861-01, AK27-01 and YA222-02 (V-lineage) are shown in Figures 2 and 3 . The results showed that the antibody-positive rate to YA222-02 was similar to that of YA861-01 (r=0 . 72, P=0 . 000) (Fig. 2) , but different from that of AK27-01 (r=0 . 15, P=0 . 19) (Fig. 3) . In other words, the herd immunity Several previous studies have indicated such discrepancies in antigenicity between egggrown influenza antigens (standard antigens in this study) and tissue-cultured antigens [21] [22] [23] [24] [25] . We need to resolve such technical issues in order to build an effective surveillance system with better predictability.
In conclusion, we report herein our success and failure in predicting the main lineage of influenza B Therefore, a careful watch is required to distinguish these two lineages in order to provide more effective public-health strategies against influenza B epidemics. To implement this objective, it is necessary to continue with the epidemiological study of influenza B lineages, using virus isolation, serological analysis and modern molecular technology, without being discouraged by errors in prediction [26] .
